CAR-T cells beyond CD19, UnCAR-Ted territory
- PMID: 30632631
- DOI: 10.1002/ajh.25398
CAR-T cells beyond CD19, UnCAR-Ted territory
Abstract
CAR-T cells have made dramatic inroads in targeting CD19-positive B-cell malignancies. This review focuses on application of CAR-T cells in hematologic malignancies beyond targeting CD19, with specific attention to Hodgkin's lymphoma and acute myeloid leukemia.
© 2019 Wiley Periodicals, Inc.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
